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Surgical Management of Adnexal
Masses in Pregnancy
Siew-Fei Ngu, MBBS, MRCOG, Vincent Y. T. Cheung, MBBS, FRCOG, FRCSC,
Ting-Chung Pun, MBBS, FRCOG
ABSTRACT
Background and Objectives: Our objective was to re-
view the surgical management, surgical outcomes, and
obstetric outcomes of adnexal masses in pregnancy.
Methods: A retrospective review was performed of preg-
nant women before 20 weeks of gestation who underwent
laparoscopy or laparotomy for management of an adnexal
mass during the period of January 2005 to June 2012 at a
university-affiliated hospital.
Results: Thirty-five pregnant women underwent surgical
removal of adnexal masses during the 7.5-year study pe-
riod: 21 (60.0%) underwent laparoscopic surgery, and 14
(40.0%) underwent laparotomy. The left upper quadrant
entry technique was used in 20 women. Conversion to
laparotomy was required in 2 women because of exten-
sive pelvic adhesions. The mean gestational age at surgery
was 15.2  1.9 weeks. All women had undergone ovarian
cystectomy. A malignant mass was found in 3 (8.6%)
women. The laparoscopy group had a significantly less
blood loss (67.4  55.8 vs 153.6  181.0 mL, P  .048)
and shorter mean hospital stay (2.8  1.0 vs 3.8  1.1
days, P  .006) than the laparotomy group. One woman
miscarried soon after surgery. There was no significant
difference in obstetric outcomes between the laparoscopy
and laparotomy groups.
Conclusion: Surgical management of adnexal masses
during pregnancy appears to have favorable outcomes for
the mother and the fetus.
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INTRODUCTION
The incidence of adnexal masses during pregnancy before
14 weeks of gestation varies from 6% to 25% in longitu-
dinal studies.1,2 Most of these adnexal masses are func-
tional ovarian cysts and generally resolve during preg-
nancy, leaving between 0.7% and 1.7% of women with
persistent masses.1,2 Although ovarian cyst torsion, hem-
orrhage, or rupture leading to abdominal pain are uncom-
mon in pregnancy, some women may require emergency
surgery for these complications. Women with persistent
masses may also opt for surgery in the second trimester of
pregnancy if malignancy is suspected on ultrasonography
images or to prevent cyst complications, which may ne-
cessitate emergency surgery in the third trimester, which
adds an increased risk of complications.3 In a study by
Whitecar et al, women who underwent laparotomy after
23 weeks’ gestation had a 50% risk of adverse perinatal
outcome.3
Traditionally, laparotomy has been used to remove ad-
nexal masses during pregnancy. However, increasing ev-
idence suggests that laparoscopic treatment of adnexal
masses in pregnancy is safe and effective.4–6 Various lapa-
roscopic entry techniques such as open Hassan, Palmer’s
point, or left upper quadrant (LUQ) entry have been used
in pregnancy.
In this retrospective study, we review the surgical man-
agement of adnexal masses in pregnant women and as-
sess their surgical and obstetric outcomes.
MATERIALS AND METHODS
Queen Mary Hospital is a regional university-affiliated
hospital with approximately 4000 deliveries per year. Eth-
ical approval was obtained from the local institutional
review board. From the operation list database we iden-
tified pregnant women who underwent surgery for ad-
nexal mass before 20 weeks of gestation during the period
between January 2005 and June 2012. All surgical proce-
dures were recorded in a clinical database immediately
after surgery (Clinical Management System, Hospital Au-
thority, Hong Kong). A retrospective review of the data-
base was performed for all patients. A database was set up
with Microsoft Excel for Windows (Redmond, Washing-
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ton, USA) to facilitate data entry and retrieval. Demo-
graphic data, ultrasonography findings, indications for
surgery, operative procedure, intraoperative findings and
diagnosis, histology reports, and complications were re-
corded. Obstetric outcomes of the pregnancy were re-
viewed when available. Results were expressed as pro-
portions and mean and standard deviation when
appropriate. Findings of women who underwent laparos-
copy (“Laparoscopy” group) were compared with women
who underwent laparotomy (“Laparotomy” group) using
the t test for continuous variables that were normally
distributed or the Mann-Whitney U test if they were not
normally distributed, and the Fisher exact or 2 tests for
dichotomous outcomes. Statistical significance was set
as 5%.
The treatment of each woman was individualized and
determined by the clinical symptoms, gestational age,
ultrasonography findings, and the woman’s choice. Mag-
netic resonance imaging or computed tomography was
not routinely performed. CA-125 levels were not mea-
sured. All surgeries were performed under general anes-
thesia by either a senior surgeon or a senior resident
under supervision. In our unit, laparoscopic surgery was
generally preferred for women with a mean cyst diameter
of 10 cm, whereas laparotomy was performed for
women with a mean cyst diameter of 10 cm; but flexi-
bility of this approach was allowed at the discretion of the
operating gynecologist. For laparotomy, a suprapubic
transverse or subumbilical midline skin incision was made
based on mass size, preoperative scarring, or the sur-
geon’s preference. For laparoscopy, closed laparoscopic
entry with the left upper quadrant approach or umbilical
approach was used based on gestational age, mass size,
previous surgery, or the surgeon’s preference. The tech-
niques of the LUQ approach in our institution have been
described previously.7 In summary, after general anesthe-
sia was administered, a nasogastric tube was inserted to
decompress the stomach. Then a small skin incision was
made at the ninth or tenth intercostal space at the anterior
axillary line, and a Veress needle was inserted. A pneu-
moperitoneum was created by insufflation of carbon di-
oxide until an abdominal pressure of 25 mm Hg was
achieved. A second skin incision of 6 to 7 mm was made
just below the left subcostal margin and a 6-mm cannula
was inserted. The peritoneal cavity was visualized with a
5-mm 0-degree laparoscope, and secondary ports were
inserted at the lower quadrants under direct vision.
RESULTS
During the 7.5-year study period, 35 pregnant women
underwent surgery for adnexal masses before 20 weeks of
gestation. The clinical characteristics of the women are
presented in Table 1. Overall, in 30 (85.7%) women, the
adnexal masses were detected incidentally on ultrasonog-
raphy during the women’s first trimester of pregnancy: 4
(11.4%) presented during the first trimester with abdomi-
nal pain, and 1 (2.9%) presented with abdominal disten-
tion. The indications for surgery in 33 women were per-
sistent adnexal mass or suspicion of malignancy. Two
Table 1.
Patient Characteristics and Surgical Outcomes
Total (N  35) Laparoscopy (n  21) Laparotomy (n  14) P value
Characteristics
Age (y) 31.5  5.4 31.4  4.3 31.6  7.0 .911
Parity 0.3  0.5 0.2  0.5 0.3  0.5 .789
Gestational age at surgery (wk) 15.2  1.9 15.1  1.8 15.4  2.2 .701
Mean cyst diameter (cm) 7.9  2.1 6.9  1.4 9.5  1.9  .001
Emergency surgery, n (%) 2 (5.7) 0 (0) 2 (5.7) .153
Bilateral mass, n (%) 4 (11.4) 1 (2.9) 3 (8.6) .279
Surgical outcomes
Operative time (min) 82.5  40.5 92.5  44.4 67.6  29.3 .074
Blood loss (mL) 101.9  127.3 67.4  55.8 153.6  181.0 .048
Hospital stay (d) 3.2  1.1 2.8  1.0 3.8  1.1 .006
Values are presented as mean  standard deviation, except where otherwise indicated.
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women with incidentally detected adnexal mass required
emergency surgery at 14 and 17 weeks of gestation, re-
spectively, for suspected torsion; however, torsion was
not confirmed at surgery. All except one woman under-
went surgery in the second trimester of pregnancy; one
woman had surgery performed at 11 weeks of gestation
because of suspicion of malignancy.
Of the 35 women, 23 (65.7%) underwent laparoscopy and
12 (34.3%) underwent laparotomy. For laparoscopic entry,
20 (87.0%) women underwent the LUQ approach and 3
(13.0%) underwent the umbilical approach. The intended
surgery was completed laparoscopically in 21 (91.3%)
women, whereas 2 (8.7%) required conversion to laparot-
omy because of extensive pelvic adhesions. The 2 women
who required conversion to laparotomy were included in
the laparotomy group for analysis. Of 14 women who
underwent laparotomy, 7 (50%) had a suprapubic trans-
verse skin incision and 7 (50%) had a subumbilical mid-
line incision. All women underwent an ovarian cystec-
tomy. For laparoscopic surgery, the cysts were removed
using a specimen retrieval bag. The laparoscopy group
had significantly less blood loss and a shorter mean hos-
pital stay than did the laparotomy group (Table 1). One
woman who had laparoscopic surgery had postoperative
acute retention of urine requiring insertion of a Foley
catheter, which was removed after 1 day.
The pathologic diagnoses are presented in Table 2. Over-
all, the diagnoses were benign masses in 32 (91.4%)
women and malignant masses in 3 (8.6%) women. After
ovarian cystectomy at 13 weeks of gestation, the woman
with a borderline mucinous ovarian tumor was treated
conservatively during the rest of her pregnancy and de-
livered at 38 weeks’ gestation. The two women with
ovarian clear cell carcinoma were given chemotherapy
during pregnancy: one received carboplatin and pacli-
taxel and delivered at 38 weeks’ gestation; the other, with
small focus of clear cell carcinoma in an endometrioma,
received carboplatin and delivered at 36 weeks’ gestation.
All 3 women with malignant masses had cesarean delivery
followed by surgical staging in the same setting, and all of
the specimens were negative for malignancy.
The obstetric outcomes were available for 33 women
(Table 3). There was one pregnancy loss, which occurred
2 days after surgery in a woman who had a planned
laparotomy at 20 weeks’ gestation; she had a spontaneous
miscarriage after she developed abdominal pain and vag-
inal bleeding and was found to have a fully dilated cervix
with bulging forewaters. There were no significant differ-
ences in the obstetric outcomes between the laparoscopy
or laparotomy groups. All women delivered after 35
weeks’ gestation with good obstetric outcomes.
DISCUSSION
The results of the present study demonstrate that surgical
management of adnexal masses in pregnancy appears to
be safe, with respect to both the mother and the fetus,
with comparable surgical and obstetric outcomes between
women who underwent laparoscopy and those who un-
derwent laparotomy.
Although several studies have reported the safety of ad-
nexal mass removal during the first trimester of preg-
nancy,8,9 it is generally avoided to allow time for sponta-
neous resolution and to reduce the risk of spontaneous
miscarriage. However, delaying surgery until the second
trimester of pregnancy poses a technical challenge, espe-
cially if laparoscopic surgery is performed. One potential
complication is inadvertent injury of the gravid uterus by
the Veress needle or trocar, causing bleeding, leakage of
amniotic fluid, or miscarriage.10 Furthermore, there may
be difficulty achieving adequate visualization because of
the limited space between the laparoscope and the ad-
nexal mass, especially if the umbilical trocar is used for
laparoscope insertion.
The recommended laparoscopic entry technique in preg-
nancy includes the LUQ approach or the open laparo-
scopic approach.11 The LUQ approach has been used
extensively in patients at high risk for periumbilical adhe-
sions. Recently, laparoscopic removal of adnexal masses
in the second trimester of pregnancy using the LUQ ap-
proach has been shown to be feasible and safe.7,12 Stepp
Table 2.
Pathologic Diagnosis
Pathologic diagnosis N (%)
Benign mass
Mature cystic teratoma 15 (42.8)
Endometrioma 7 (20.0)
Corpus luteum 3 (8.6)
Mucinous cystadenoma 3 (8.6)
Serous cystadenoma 2 (5.7)
Others 2 (5.7)
Malignant mass
Borderline mucinous tumor 1 (2.9)
Clear cell carcinoma 2 (5.7)
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et al12 reported the use of the LUQ approach in 7 women
for treatment of adnexal mass in the second trimester of
pregnancy, with no maternal or fetal complications. In the
present study, 20 women underwent laparoscopy using
the LUQ approach in the second trimester of pregnancy at
a mean gestational age of 15 weeks. There was no com-
plication related to entry technique, namely, inadvertent
injury to the gravid uterus or ovarian cyst by the Veress
needle or trocar. In our experience, another advantage of
the LUQ approach compared with the open approach
with placement of the trocar at the umbilicus is that it
provides better panoramic vision by allowing adequate
distance between the laparoscope and the adnexal mass.
Moreover, most of the intended surgeries were completed
without the need for an additional trocar at the umbilicus.
One of the main concerns with an adnexal mass is the risk
of malignancy. In most of the published series, the re-
ported incidence of ovarian cancer in pregnancy ranges
from 1 in 5000 to 1 in 47 000 live births, with 2% to 6% of
persistent adnexal masses found to be malignant.13 In the
present study, the rate of malignancy was 1 in 10 000 live
births, or 8.6% of persistent masses, which is comparable
with the reported rates. However, in a retrospective study
of 60 adnexal masses resected during pregnancies over a
12-year period, Sherard et al13 reported a malignancy rate
of 13%, which was more than twice the previously re-
ported incidence. Most of the reported rates of malig-
nancy, including that in the present study, derive from
retrospective studies, which have limitations. The rates
depend on the selection criteria by which an adnexal mass
would be removed during pregnancy. In longitudinal
studies that evaluated the prevalence of adnexal mass in
early pregnancy and then observed the natural history of
the mass through pregnancy, the rate of malignancy was
found to be lower.1,2
Our study has limitations. We included only women who
underwent surgery before 20 weeks’ gestation, and we do
not have information on women who underwent surgery
later in pregnancy. Moreover, definite conclusions cannot
be made from the small number of patients. However, our
findings help us when counseling women with adnexal
masses during pregnancy in reassuring them that surgical
management of the masses appears to be safe for the
mother and the fetus.
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